×
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF
$ 40.00
Cost-Effectiveness of 12-Month Therapeutic Assertive Community Treatment as Part of Integrated Care Versus Standard Care in Patients With Schizophrenia Treated With Quetiapine Immediate Release (ACCESS Trial) PDF quantity
$ 40.00
×
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF
$ 40.00
Ziprasidone in Treatment-Resistant Schizophrenia: A 52-Week, Open-Label Continuation Study PDF quantity
$ 40.00
×
Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF
$ 40.00
Psychiatric Care of the Patient With Hepatitis C: A Review of the Literature PDF quantity
$ 40.00
×
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression PDF
$ 40.00
Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression PDF quantity
$ 40.00
×
A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder PDF
$ 40.00
A Preliminary, Randomized Trial of Fluoxetine, Olanzapine, and the Olanzapine-Fluoxetine Combination in Women With Borderline Personality Disorder PDF quantity
$ 40.00
×
"Extended" Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia: A Double-Blind, Placebo-Controlled Trial PDF
$ 40.00
"Extended" Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia: A Double-Blind, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study PDF
$ 40.00
Trends in Medication Prescribing in Patients With PTSD From 2009 to 2018: A National Veterans Administration Study PDF quantity
$ 40.00
×
Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression. PDF
$ 40.00
Mood Symptoms, Functional Impairment, and Disability in People With Bipolar Disorder: Specific Effects of Mania and Depression. PDF quantity
$ 40.00
×
Nefazodone in the Treatment of Generalized Social Phobia: A Randomized, Placebo-Controlled Trial PDF
$ 40.00
Nefazodone in the Treatment of Generalized Social Phobia: A Randomized, Placebo-Controlled Trial PDF quantity
$ 40.00
×
Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies PDF
$ 40.00
Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
